Breast and Ovarian Oncology Research Program

Laura J. Havrilesky, MD,MHSc
Recent Publications

Secord AA,Havrilesky LJ,O'Malley DM,Bae-Jump V,Fleming ND,Broadwater G,Cohn DE,Gehrig PA. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.,9/1/2009, (442-7) - Gynecologic oncology Abstract [More ...]

Fader AN,Starks D,Gehrig PA,Secord AA,Frasure HE,O'Malley DM,Tuller ER,Rose PG,Havrilesky LJ,Moore KN,Huh WK,Axtell AE,Kelley JL,Zanotti KM. An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).,8/25/2009, (-) - Gynecologic oncology Abstract [More ...]

Havrilesky LJ,Secord AA,O'Malley DM,Broadwater G,Bae-Jump V,Cohn DE,Gehrig PA. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.,8/1/2009, (279-83) - Gynecologic oncology Abstract [More ...]

Havrilesky LJ,Maxwell GL,Myers ER. Cost-effectiveness analysis of annual screening strategies for endometrial cancer.,4/18/2009, (-) - American journal of obstetrics and gynecology Abstract [More ...]

Alvarez Secord A,Bae-Jump V,Havrilesky LJ,Calingaert B,Clarke-Pearson DL,Soper JT,Gehrig PA. Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologists.,4/1/2009, (447-54) - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Abstract [More ...]

Fader AN,Drake RD,O'Malley DM,Gibbons HE,Huh WK,Havrilesky LJ,Gehrig PA,Tuller E,Axtell AE,Zanotti KM. Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.,3/20/2009, (-) - Cancer Abstract [More ...]

Wu JM,Siddiqui NY,Amundsen CL,Myers ER,Havrilesky LJ,Visco AG. Cost-Effectiveness of Botulinum Toxin A Versus Anticholinergic Medications for Idiopathic Urge Incontinence.,3/16/2009, (-) - The Journal of urology Abstract [More ...]

Neubauer NL,Havrilesky LJ,Calingaert B,Bulusu A,Bernardini MQ,Fleming ND,Bland AE,Secord AA. The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma.,3/1/2009, (511-6) - Gynecologic oncology Abstract [More ...]

Rubatt JM,Darcy KM,Hutson A,Bean SM,Havrilesky LJ,Grace LA,Berchuck A,Secord AA. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.,3/1/2009, (469-74) - Gynecologic oncology Abstract [More ...]

Fader AN,Nagel C,Axtell AE,Zanotti KM,Kelley JL,Moore KN,Secord AA,Walsh CS,Huh WK,Gehrig PA,Gibbons H,Rose PG,Havrilesky LJ,Tuller E,Drake RD,Bottsford-Miller J,O'Malley DM. Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.,3/1/2009, (558-62) - Gynecologic oncology Abstract [More ...]



NOTE: For more publications on this researcher, please visit Pubmed - A service of the National Library of Medicine and the National Institutes of Health.

Duke Comprehensive Cancer Center Accolades